⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ESPR News
Esperion Therapeutics, Inc.
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
globenewswire.com
ESPR
KKR
Esperion to Report Fourth Quarter and Full Year 2025 Financial Results on March 10
globenewswire.com
ESPR
Esperion to Participate in The 2026 Citizens Life Sciences Conference
globenewswire.com
ESPR
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
globenewswire.com
ESPR
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
ESPR
Everspring Named a 2026 Best Places to Work for the Fifth Year as Company Accelerates AI Innovation in Higher Education
businesswire.com
ESPR
Atherosclerotic Cardiovascular Disease Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2025–2034) | DelveInsight
globenewswire.com
AMGN
ARWR
IONS
NVS
NVO
MRK
LLY
REGN
ESPR
ALNY
VRTX
XBI
AI Chipsets in Telecommunications and Computing Market Research Report 2025-2030: an Essential Roadmap for Navigating the Complex and Lucrative Future of the AI Chipset Marketplace
globenewswire.com
GOOGL
MSFT
META
AAPL
IBM
TSLA
HPE
DELL
WD
AMAT
NVDA
INTC
AMD
MU
QCOM
AVGO
ADI
TXN
AMZN
SNPS
CDNS
ON
STM
NXPI
INFY
WDC
KLAC
LRCX
ASML
SMCI
CRSP
ESPR
ARM
SYNA
CEVA
SIF
MAR
MCHP
SE
Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
ESPR
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
businesswire.com
PCAR
ESPR
PRTA
LLY
CRBU
RAPT